<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>West Asia Organization for Cancer Prevention (WAOCP), APOCP's West Asia Chapter.</PublisherName>
				<JournalTitle>Asian Pacific Journal of Cancer Prevention</JournalTitle>
				<Issn>1513-7368</Issn>
				<Volume>17</Volume>
				<Issue>4</Issue>
				<PubDate PubStatus="epublish">
					<Year>2016</Year>
					<Month>04</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Randomized-Control Screening Trials to Lower Gall Bladder Cancer Mortality in High Risk Populations</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>2325</FirstPage>
			<LastPage>2327</LastPage>
			<ELocationID EIdType="pii">32397</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Manigreeva </FirstName>
					<LastName>Krishnatreya</LastName>
<Affiliation>Cancer Epidemiology and Biostatistics Guwahati, India</Affiliation>

</Author>
<Author>
					<FirstName>Amal Chandra</FirstName>
					<LastName>Kataki</LastName>
<Affiliation></Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>1970</Year>
					<Month>01</Month>
					<Day>01</Day>
				</PubDate>
			</History>
		<Abstract>Gall bladder cancer is generally fatal. The high morbidity and mortality due to gall bladder cancer exerts a significant impact on efforts towards cancer control in high risk populations of the World and a rationale program for control of gall bladder cancer mortality has remained as an unmet need in these populations. Currently there are no effective strategies for controlling gall bladder cancer mortality. This mini review is to highlight the need and feasibility for secondary prevention of gall bladder cancer by screening in high risk populations. A way forward is to assess the role of secondary prevention of gall bladder cancers by conducting randomized- controlled screening trials in high risk populations.</Abstract>
<ArchiveCopySource DocType="pdf">https://journal.waocp.org/article_32397_200415fd997f2f6a3ac3795888769bc4.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
